Company Dynamic

It’s premature to comment on whether Sabic might increase its stake until regulators approve the transaction, likely in the third quarte...

• Sabic
• Chemical
• 2025

Sabic has formed a joint venture with Exxon Mobil to build an ethylene plant in Corpus Christi, Texas, with a final investment decision ...

• Saudi
• Chemical
• Houston

Yangzi PC has recently restarted the long-shut No.2 unit and the unit has a nameplate capacity of 350 kt/year.

• Yangzi PC
• PTA

Compugen, a provider of predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, has entered into an exclusive license agreement with MedImmune (www.medimmune.com), the global biologics research and development arm...

Therapure Biopharma has launched its plasma products and technology division as Evolve Biologics. Evolve's leadership team consists of chief executive officer Blaine Forshage; chief commercial officer, David Holliday; and chief financial officer...

JXTG Nippon Oil & Energy Corporation has announced it has agreed to sell Irvine Scientific Sales Company, Inc. and IS Japan Co., Ltd. to FUJIFILM Corporation (FujiFilm).

Rhythm Pharmaceuticals has acquired exclusive, worldwide rights from Takeda to develop and commercialize T-3525770 (now RM-853).

• Development
• Preclinical
• production

JXTG Nippon Oil & Energy Corporation has announced it has agreed to sell Irvine Scientific Sales Company, Inc. and IS Japan Co., Ltd. to FUJIFILM Corporation (FujiFilm).

• R&D
• acquisition
• FujiFilm

Compugen, a provider of predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, has entered into an exclusive license agreement with MedImmune (www.medimmune.com), the global biologics research and development arm...

• immunotherapy
• patients
• Development
• license

TiGenix NV and Takeda Pharmaceutical Company have announced that the European Commission (EC) has approved Alofisel (darvadstrocel), previously Cx601, for the treatment of complex perianal fistulae in adult patients with nonactive/mildly active ...

• Takeda
• disease
• TiGenix

AstraZeneca is a global, science-led biopharmaceutical company, announced that the European Commission has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia.

AstraZeneca is a global, science-led biopharmaceutical company, announced that the European Commission has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia.

• AstraZeneca
• EU
• approval
• Lokelma

Dominion Colour Corporation (DCC) offers a broad color palette of pigments worldwide. To ensure ongoing supply to the European Union (EU), DCC has successfully completed REACH registration for a wide range of products.

Evonik Corporation’s High Performance Polymers Business Line announced a sales agency agreement with Seher Consulting Ltd. for its VESTAMID® NRG polyamide 12 product line used in oil and gas applications for the Canadian region.

• Evonik
• Contract
• Seher

Pengwei plans to shut the 900kta PTA plant for two-month turnaround at the end of the month.Its upstream PX unit will be shut around Apr 10.

• Jiaxing
• PTA

Solvay SA is taking a new step in its transformation, putting its customers at the core of its organization to enhance its long-term growth as an advanced materials and speciality chemicals company.

Shell Brasil Petroleo, a subsidiary of Royal Dutch Shell plc (Shell), has won four additional deep-water exploration blocks in the Campos and Potiguar basins. Bringing its total operated presence offshore Brazil to 18 blocks. In the 15th deep-water...

" Werner Fuhrmann, CEO of AkzoNobel Specialty Chemicals, said: "Specialty Chemicals is a strong and profitable business with highly skil...

• AkzoNobel
• Specialty
• Chemicals

Petroliam Nasional Berhad (Petronas) and Saudi Aramco has announced the formation of two joint ventures (JV) for the refinery and petrochemical integrated development (RAPID) project.

• Malaysia
• Petronas
• refinery
• petrochemical

Idifarma has launched new GMP spray drying capabilities. The new capabilities will allow the contract development and manufacturing organizations (CDMO) to offer spray drying technology for highly potent drugs up to Category 4 OEL/OEB.